MENS Stock Chart & Stats
$2.24
-$0.01(-0.45%)
At close: 4:00 PM EDT
$2.24
-$0.01(-0.45%)
Day’s Range― - ―
52-Week Range$1.43 - $67.00
Previous Close$2.27
Volume34.51K
Average Volume (3M)406.92K
Market Cap
$159.60M
Enterprise Value$139.02M
Total Cash (Recent Filing)$1.18M
Total Debt (Recent Filing)$18.55M
Price to Earnings (P/E)―
Beta2.55
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding76,027,664
10 Day Avg. Volume380,433
30 Day Avg. Volume406,924
Financial Highlights & Ratios
PEG Ratio-1.01
Price to Book (P/B)-11.58
Price to Sales (P/S)0.00
P/FCF Ratio-94.84
Enterprise Value/Market Cap0.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-77.62
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Jyong Biotech Ltd. News
MENS FAQ
What was Jyong Biotech Ltd.’s price range in the past 12 months?
Jyong Biotech Ltd. lowest stock price was $1.43 and its highest was $67.00 in the past 12 months.
What is Jyong Biotech Ltd.’s market cap?
Jyong Biotech Ltd.’s market cap is $159.60M.
When is Jyong Biotech Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jyong Biotech Ltd.’s earnings last quarter?
Currently, no data Available
Is Jyong Biotech Ltd. overvalued?
According to Wall Street analysts Jyong Biotech Ltd.’s price is currently Overvalued.
Does Jyong Biotech Ltd. pay dividends?
Jyong Biotech Ltd. does not currently pay dividends.
What is Jyong Biotech Ltd.’s EPS estimate?
Jyong Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jyong Biotech Ltd. have?
Jyong Biotech Ltd. has 76,027,664 shares outstanding.
What happened to Jyong Biotech Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Jyong Biotech Ltd.?
Currently, no hedge funds are holding shares in MENS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Jyong Biotech Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
226.39%
Trailing 12-Months
Company Description
Jyong Biotech Ltd.
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
Technical Analysis
Protalix
―
Spero Therapeutics
―
Black Diamond Therapeutics
―
Connect Biopharma Holdings
―
Molecular Partners
―
Ownership Overview
―
Insiders
0.06% Mutual Funds
0.02% Other Institutional Investors
99.45% Public Companies and
Individual Investors